Minerva Neurosciences, Inc. announced that it has entered into a securities purchase agreement to issue an aggregate of 1,425,000 shares at a price of $10 per share for the gross proceeds of $14.25 million and 575,575 pre-funded warrants at a price of $9.99 per warrant for the gross proceeds of $5.749994 million for the total gross proceeds of $19.999994 million on June 27, 2023. Each warrant has an exercise price of 0.01 per warrant. The transaction is expected to close on or about June 30, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.436 USD | +0.27% | -1.75% | -60.38% |
Feb. 27 | Sector Update: Health Care Stocks Ease Late Afternoon | MT |
Feb. 27 | Top Midday Decliners | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-60.38% | 17.04M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- NERV Stock
- News Minerva Neurosciences, Inc.
- Minerva Neurosciences, Inc. announced that it expects to receive $19.999994 million in funding